Market Place
Sourcing Support
Fresenius Kabi Named Top US Employer for 4th Year In a Row
21 Jan 2026 //
PRESS RELEASE
Fresenius Kabi, TQ Therapeutics Partner On Cell Therapy Tech
14 Jan 2026 //
PRESS RELEASE
Fresenius Kabi Introduces New Presentation of Otulfi
06 Jan 2026 //
PRESS RELEASE
Fresenius Kabi Launches Room-Temperature Stable Rocuronium
18 Dec 2025 //
PRESS RELEASE
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection
18 Dec 2025 //
PRESS RELEASE
Fresenius Kabi Expands Operating Room Portfolio with New Simplist
02 Dec 2025 //
PRESS RELEASE
Fresenius Kabi Introduces Dalbavancin for Injection
24 Nov 2025 //
PRESS RELEASE
Fresenius Rolls Out Adaptive Nomogram at BioLife Centers
12 Nov 2025 //
PRESS RELEASE
FDA Grants Interchangeable Desig to Fresenius Kabi’s Biosimilar
29 Oct 2025 //
PRESS RELEASE
Fresenius Kabi Announces 13 New Inductees Into the National Blood
22 Oct 2025 //
PRESS RELEASE
Fresenius Kabi Receives Two Major Awards for Supply & Service
25 Sep 2025 //
PRESS RELEASE
Fresenius Expands Biosimilars Portfolio With The Launch
07 Sep 2025 //
PRESS RELEASE
Fresenius Kabi &AABB Announce 20th Anniversary of Blood Collector
07 Sep 2025 //
PRESS RELEASE
Fresenius Kabi Leads EASYGEN to Decentralize CAR-T Therapy
26 Aug 2025 //
PRESS RELEASE
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
17 Jul 2025 //
PRESS RELEASE
Fresenius Kabi`s Generics MgCl Receives Approval in US
07 Jul 2025 //
FDA
Fresenius Kabi Launches Denosumab Biosimilars in the U.S.
01 Jul 2025 //
PRESS RELEASE
Fresenius Receives FDA Approval for their Denosumab Biosimilars
28 Mar 2025 //
BUSINESSWIRE
Fresenius Kabi Launches Calcitonin Salmon Injection
10 Feb 2025 //
BUSINESSWIRE
Fresenius Kabi`s Biologic Otulfi (Ustekinumab) Receives Approval in US
27 Sep 2024 //
FDA
Fresenius Kabi`s Generics Pantoprazole Sodium Receives Approval in US
01 Aug 2024 //
FDA
Fresenius Kabi USA`s Generics Daptomycin Receives Approval in US
01 Aug 2024 //
FDA
Fresenius Kabi Usa Generic Sodium Chloride Receives Approval in US
24 Jun 2024 //
FDA
Fresenius Kabi USA Wins Drug Shortage Guardian Award
06 Jun 2024 //
BUSINESSWIRE
Fresenius Kabi Usa`s Generic Adalimumab-Aacf Receives Approval in US
04 Jun 2024 //
FDA
Fresenius`s Biologic Stimufend (Pegfilgrastim) Receives Approval in the U.S.
01 Sep 2022 //
FDA
Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
29 Jul 2022 //
BUSINESSWIRE
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Inj.
25 Jul 2022 //
BUSINESSWIRE
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
18 Jul 2022 //
BUSINESSWIRE
Fagron expands its US sterile compounding footprint with East coast acquisition
05 Jul 2022 //
GLOBENEWSWIRE
Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US
08 Jun 2022 //
FDA
Fresenius Kabi Introduces New Generic for Non-Squamous NSCLC
31 May 2022 //
BUSINESSWIRE
Dr. Brandee Pappalardo Joins Fresenius Kabi as CMO for N. America
18 May 2022 //
BUSINESSWIRE
Toxins In Silicone Tubing Leads To FDA Warning
09 May 2022 //
MEDTECH INSIGHT
Fresenius Kabi USA Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma
02 May 2022 //
BUSINESSWIRE
Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection
27 Apr 2022 //
BUSINESSWIRE
Fresenius Kabi USA,`s Generic Sodium Phosphate Receives Approval in the U.S.
30 Mar 2022 //
FDA
Fresenius Sues Zydus Over Patents for Rare Thyroid Disease Drug
30 Mar 2022 //
BLOOMBERGLAW
Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP
07 Mar 2022 //
BUSINESSWIRE
Fresenius & Phlow Corp. Form Alliance to Enhance Supply of Essential Medicines
14 Oct 2021 //
BUSINESSWIRE
FDA Issues Form 483 to Fresenius Kabi USA LLC
29 Jan 2021 //
FDA
Recall report: Fresenius Kabi yanks inflammatory med Ketorolac after finding
11 Jan 2021 //
ENDPTS
Fresenius Kabi USA`s Generic Potassium Cl: Sodium Cl Receives Approval In US
21 Sep 2020 //
FDA
Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US
09 Sep 2020 //
FDA
Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US
09 Sep 2020 //
FDA
Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US
09 Sep 2020 //
FDA
Fresenius Kabi Introduces RFID Smart Labels for Essential Meds
21 Aug 2020 //
CONTRACTPHARMA
Fresenius Kabi`s Generic Oxacillin SodiumReceives Approval in US
25 Jul 2020 //
FDA
Fresenius Kabi Adds Micafungin for Inj to Expanding Anti-Infective Portfolio
12 May 2020 //
BUSINESSWIRE
